DK1270575T3 - Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat - Google Patents

Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat

Info

Publication number
DK1270575T3
DK1270575T3 DK01917764T DK01917764T DK1270575T3 DK 1270575 T3 DK1270575 T3 DK 1270575T3 DK 01917764 T DK01917764 T DK 01917764T DK 01917764 T DK01917764 T DK 01917764T DK 1270575 T3 DK1270575 T3 DK 1270575T3
Authority
DK
Denmark
Prior art keywords
hitherto
crystalline form
pyrrolidylthiocarbapenem derivative
pyrrolidylthiocarbapenem
derivative
Prior art date
Application number
DK01917764T
Other languages
Danish (da)
English (en)
Inventor
Izumi Saitoh
Masayuki Takahira
Toshio Kawakita
Yasuyuki Yoshioka
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18614158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1270575(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK1270575T3 publication Critical patent/DK1270575T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DK01917764T 2000-03-31 2001-03-30 Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat DK1270575T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000099868 2000-03-31

Publications (1)

Publication Number Publication Date
DK1270575T3 true DK1270575T3 (da) 2006-01-16

Family

ID=18614158

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01917764T DK1270575T3 (da) 2000-03-31 2001-03-30 Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat

Country Status (17)

Country Link
US (5) US20030153191A1 (enExample)
EP (1) EP1270575B1 (enExample)
JP (1) JP3375084B2 (enExample)
KR (1) KR100472842B1 (enExample)
CN (1) CN1192030C (enExample)
AT (1) ATE304014T1 (enExample)
AU (2) AU4469201A (enExample)
BR (1) BRPI0109712B8 (enExample)
CA (1) CA2404703C (enExample)
CY (2) CY1105674T1 (enExample)
DE (1) DE60113243T2 (enExample)
DK (1) DK1270575T3 (enExample)
ES (1) ES2252205T3 (enExample)
MX (1) MXPA02009592A (enExample)
TW (1) TWI293631B (enExample)
WO (1) WO2001072750A1 (enExample)
ZA (1) ZA200207675B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3375084B2 (ja) * 2000-03-31 2003-02-10 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の新型結晶
JP5004355B2 (ja) * 2001-05-10 2012-08-22 塩野義製薬株式会社 アセチルチオピロリジン誘導体の製法
JP2005509037A (ja) * 2001-11-16 2005-04-07 ランバクシー ラボラトリーズ リミテッド 結晶イミペネム製造方法
TWI353855B (en) 2005-05-26 2011-12-11 Shionogi & Co Method for preparing an aqueous solution of doripe
JP5671204B2 (ja) * 2006-04-28 2015-02-18 株式会社カネカ カルバペネム抗生物質中間体の改良された晶析方法
CN101466713A (zh) * 2006-07-03 2009-06-24 成都地奥九泓制药厂 多尼培南的新结晶及其制备方法和用途
CN101191787B (zh) * 2006-11-21 2011-07-27 上海医药工业研究院 高效液相色谱法测定多利培南含量的方法
EP2276762B1 (en) 2008-03-24 2014-10-01 Ranbaxy Laboratories Limited Process for the preparation of sterile doripenem
CN103025733B (zh) * 2010-06-03 2015-11-25 山东轩竹医药科技有限公司 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途
CN102977101A (zh) * 2011-09-07 2013-03-20 中国人民解放军军事医学科学院毒物药物研究所 多尼培南一水合物、其药物组合物、其制备方法和用途
CN102285988B (zh) * 2011-09-08 2012-09-05 上海希迈医药科技有限公司 一种多尼培南水合物晶体及其制备方法
WO2013068910A1 (en) * 2011-11-08 2013-05-16 Ranbaxy Laboratories Limited Process for the preparation of polymorphs of doripenem
CN104072497B (zh) * 2013-03-29 2017-10-03 石药集团中奇制药技术（石家庄）有限公司 一种多尼培南新结晶及其制备方法
CN103389347B (zh) * 2013-07-26 2015-12-09 深圳市海滨制药有限公司 高效液相色谱法测定多尼培南的方法
BR112016025281B8 (pt) * 2014-04-28 2023-10-03 Jw Pharmaceutical Corp Cristal de anidrido de doripenem, método para preparar um cristal de anidrido de doripenem e solvato de doripenem
KR20160007679A (ko) 2016-01-04 2016-01-20 제일약품주식회사 도리페넴의 신규한 결정형

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
US5539102A (en) * 1992-02-21 1996-07-23 Shionogi Seiyaku Kabushiki Kaisha Production method for sulfamide
ATE223916T1 (de) * 1994-05-02 2002-09-15 Shionogi & Co Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
JP3558684B2 (ja) * 1994-06-28 2004-08-25 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の乾燥方法
JP3375084B2 (ja) * 2000-03-31 2003-02-10 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の新型結晶
BRPI0407480A (pt) * 2003-02-14 2006-02-07 Shionogi & Co Cristal de intermediário sintético de carbapenem
EP2401278A4 (en) 2009-02-26 2012-07-04 Orchid Chemicals & Pharm Ltd IMPROVED PROCESS FOR THE PREPARATION OF A CARBAPENEM ANTIBIOTICS

Also Published As

Publication number Publication date
US20080207586A1 (en) 2008-08-28
AU4469201A (en) 2001-10-08
TWI293631B (enExample) 2008-02-21
AU2001244692B2 (en) 2004-10-14
BRPI0109712B8 (pt) 2021-05-25
CY1105674T1 (el) 2010-07-28
US8247402B2 (en) 2012-08-21
CY2009001I2 (el) 2009-11-04
MXPA02009592A (es) 2003-03-12
US20030153191A1 (en) 2003-08-14
CY2009001I1 (el) 2009-11-04
EP1270575A1 (en) 2003-01-02
EP1270575B1 (en) 2005-09-07
US9221823B2 (en) 2015-12-29
CN1432016A (zh) 2003-07-23
US20070060562A1 (en) 2007-03-15
CA2404703A1 (en) 2002-09-26
US20150031664A1 (en) 2015-01-29
BRPI0109712B1 (pt) 2017-10-24
EP1270575A4 (en) 2004-02-18
BR0109712A (pt) 2003-04-29
WO2001072750A1 (en) 2001-10-04
DE60113243T2 (de) 2006-02-16
ES2252205T3 (es) 2006-05-16
US20130059831A1 (en) 2013-03-07
DE60113243D1 (de) 2005-10-13
ATE304014T1 (de) 2005-09-15
CN1192030C (zh) 2005-03-09
ZA200207675B (en) 2003-09-25
CA2404703C (en) 2007-06-05
JP3375084B2 (ja) 2003-02-10
KR20020087446A (ko) 2002-11-22
KR100472842B1 (ko) 2005-03-10

Similar Documents

Publication Publication Date Title
DK1270575T3 (da) Hidtil ukendt krystallinsk form af et pyrrolidylthiocarbapenemderivat
HUT70159A (en) Oxazolidinedion derivatives, pharmaceutical compositions containing them, their production and use
AU2003278592A1 (en) A novel crystalline form of linezolid
CA2296031A1 (en) Novel spiroazabicyclic heterocyclic compounds
AU2003297291A1 (en) Substituted arylcyclopropylacetamides as glucokinase activators
MXPA03008755A (es) Derivados de 2-amino-propanol.
WO2003051846A3 (de) Substituierte phenylderivate
YU17301A (sh) KRISTALNI OBLICI EtO2C-CH2-(R)-Cgl-Aze-Pab-OH
CY1107913T1 (el) Πολυμορφικες και αλλες κρυσταλλικες μορφες cis-ftc
PT992509E (pt) Novos derivados macrolidos
ATE238298T1 (de) Tetraderivate, ihre herstellung und verwendung
DK0843967T3 (da) Anvendelse af beta-aminopripionsyrederivater som fungicider
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
CY1107112T1 (el) Κρυσταλλοι τοζιλικου suplatast
FI951992A0 (fi) Uusia substituoituja atsetidinoneja anti-inflammatorisina ja antidegeneratiivisina aineina
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
CA2347853A1 (en) Process for racemization of [2-(2-thienyl)ethylamino] (2-halogenophenyl)acetamides
PT1277750E (pt) Hidratos e cristais de um composto de acido neuraminico
ATE322481T1 (de) Zwischenverbindung zur herstellung von carvedilol
BR0112876A (pt) Processo para preparação de discodermolida e seus análogos
DE69012845D1 (de) Exo-3'-4'-O-benzyliden-3"-demethylchartreusin und seine Salze.
DE60212086D1 (de) Stabile kristalle von pyrrolverbindungen
DK0952157T3 (da) 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin
DE60119789D1 (de) Chirale gerüste und deren herstellung
SI1666463T1 (sl) Kristal indolne spojine, ki vsebuje sulfonamid, in postopek za njegovo pripravo